Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Åsa Nordling"'
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-13 (2024)
Abstract Non-alcoholic steatohepatitis (NASH) is a major health problem leading to liver fibrosis and hepatocellular carcinoma, among other diseases, and for which there is still no approved drug treatment. Previous studies in animal models and in LX
Externí odkaz:
https://doaj.org/article/d624178f30c34c49b1f19cba4df66b51
Publikováno v:
Hepatology Communications, Vol 8, Iss 3 (2024)
Background:. The prevalence of NAFLD is rapidly increasing. NAFLD can progress to NASH, fibrosis, cirrhosis, and HCC, which will soon become the main causes of liver transplantation. To date, no effective drug for NASH has been approved by the Food a
Externí odkaz:
https://doaj.org/article/be4d1e9a688741de89e4b9650a5f9230
Publikováno v:
Cells, Vol 12, Iss 2, p 302 (2023)
Connective tissue growth factor (CTGF) is involved in the regulation of extracellular matrix (ECM) production. Elevated levels of CTGF can be found in plasma from patients with liver fibrosis and in experimental animal models of liver fibrosis, but t
Externí odkaz:
https://doaj.org/article/e487a8a3eda44f67b68f4badb9d49611
Autor:
Tracey Hurrell, Vlasia Kastrinou-Lampou, Achilleas Fardellas, Delilah F. G. Hendriks, Åsa Nordling, Inger Johansson, Audrey Baze, Céline Parmentier, Lysiane Richert, Magnus Ingelman-Sundberg
Publikováno v:
Cells, Vol 9, Iss 4, p 964 (2020)
Non-alcoholic fatty liver disease affects approximately one billion adults worldwide. Non-alcoholic steatohepatitis (NASH) is a progressive disease and underlies the advancement to liver fibrosis, cirrhosis, and hepatocellular carcinoma, for which th
Externí odkaz:
https://doaj.org/article/50d081ebb12549308162f6e2a8813916
Autor:
Etienne P A Neve, Harald Köfeler, Delilah F G Hendriks, Åsa Nordling, Vladimir Gogvadze, Souren Mkrtchian, Erik Näslund, Magnus Ingelman-Sundberg
Publikováno v:
PLoS ONE, Vol 10, Iss 9, p e0138487 (2015)
Recently two novel enzymes were identified in the outer mitochondrial membrane, mARC1 and mARC2. These molybdenum containing enzymes can reduce a variety of N-hydroxylated compounds, such as N-hydroxy-guanidines and sulfohydroxamic acids, as well as
Externí odkaz:
https://doaj.org/article/ac02ed25d541439ebe9d04bfe6ab28ba
Autor:
Johansson, Marianne, Axehill, Johanna Wallén, Larsson, Åsa Nordling, Cederberg, Linda, Chiesi, Stephanie Sharo, Palmer, Erika
Publikováno v:
Incose International Symposium; Jul2024, Vol. 34 Issue 1, p1631-1645, 15p
Publikováno v:
INCOSE International Symposium. 32:133-141
Boxing Configuration Management – Configuration Change Management Meets the 4‐Box Development Model.
Publikováno v:
Incose International Symposium; Jul2023, Vol. 33 Issue 1, p71-85, 15p
Publikováno v:
Incose International Symposium; Jul2022 Supplement 2, Vol. 32, p133-141, 9p
Publikováno v:
Incose International Symposium; Jul2022, Vol. 32 Issue 1, p233-248, 16p